Home > Journals > Otorinolaringologia > Past Issues > Otorinolaringologia 2010 March;60(1) > Otorinolaringologia 2010 March;60(1):11-3

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

ORIGINAL ARTICLES   

Otorinolaringologia 2010 March;60(1):11-3

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: Italian

Use of a compound containing N-acetyl-cysteine, echinacea, uncaria and propoles in antibiotic therapy for upper respiratory infections

Beatrice F., Bucolo S.

Struttura Complessa di Otorinolaringoiatria, Ospedale San Giovanni Bosco, ASL TO2, Torino, Italia


PDF


The study compares two treatment approaches to upper respiratory infections as measured by patient self-report of changes in symptoms. The study population was divided into two homogeneous groups (age range, 18-25 years) and administered amoxicillin clavulanate, a commonly used antibiotic for such infections. One group received adjuvant antibiotic therapy with Prodefens, a compound containing N-acetyl-cysteine, echinacea, propolis and uncaria. The patients self-evaluated changes in 7 characteristic symptoms of upper respiratory infections on a 5-point Likert scale. As compared with the group given amoxicillin clavulanate alone, a significant reduction in symptom severity and duration was observed in the group that had received adjuvant antibiotic therapy with Prodefens. These preliminary results need to be substantiated with further studies on the therapeutic efficacy of combination therapy with Prodefens in the treatment of upper respiratory infections, given the increasing risk of bacterial resistance to widely used antibiotics.

top of page